相关实验视频

Updated: May 27, 2025

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Preparation and Pathogen Inactivation of Double Dose Buffy Coat Platelet Products using the INTERCEPT Blood System

Published on: December 7, 2012

2024年关于血小板产品和国际实践的国际调查

Hitoshi Ohto¹, Willy A Flegel², Pieter F van der Meer³

¹Department of Blood Transfusion and Transplantation Immunology, Fukushima Medical University School of Medicine, Fukushima, Japan; Radiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, Fukushima, Japan.

Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis

|February 19, 2025

概括

全球血小板采集和输血实践显示出显著的差异. 这项调查强调了血小板制造,保存和降低风险的各种方法,为改善全球患者护理提供了见解.

科学领域:

输血医学输血医学
血液学血液学血液学
血液银行技术血液银行技术

背景情况:

之前的国际调查已经探讨了血小板收集和输血实践.
了解目前在血小板制造,保存和输血风险降低方面的全球实践至关重要.

研究的目的:

记录在血小板制造,保存和输血风险降低方面的现代技术的实施.
通过领导调查评估血小板收集和输血实践的全球格局.

主要方法:

一份问卷分发给各个国家的血液银行和输血医学的领导者.
该调查旨在记录血小板处理和安全性先进技术的采用情况.

主要成果:

来自40个国家的52位贡献者的回答显示,实践中存在显著的异质性.
广泛采用白细胞减少 (超过70%) 和增加使用血小板添加剂溶液 (45%) 被注意到.
细菌检测系统在全球范围内使用,很少有污染的不良事件报告.

结论:

在血小板收集,处理和输血方面存在相当大的全球异质性.
结果为在当地环境中适应和采用最佳实践提供了基础.
这项研究强调,需要继续努力,标准化和提高血小板输血的安全性和有效性.

关键词:

亚菲雷西斯是指亚菲雷西斯.细菌污染是一种细菌污染.在冷藏的血小板.辐射辐射是一种辐射.减少白细胞的方法病原体灭活技术 (PIT) 是一种病原体减少技术 (PRT) 是一种技术.血小板添加剂溶液 (PAS) 的使用血小板输血输血血小板输血

更多相关视频

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Microfluidic Flow Chambers Using Reconstituted Blood to Model Hemostasis and Platelet Transfusion In Vitro

Published on: March 19, 2016

相关概念视频

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

Structure and Function of Platelets

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...